Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4+ T cell-dependent manner.
M. B. Ware, C. McQuinn, M. Y. Zaidi, H. Knochelmann, T. A. Mace, Z. Chen, C. Zhang, M. R. Farren, A. N. Ruggieri, J. Bowers, R. Shakya, A. B. Farris, G. Young, W. E. Carson, B. El-Rayes, , G. B. Lesinski
This study shows dual IL-6 and CTLA-4 blockade regresses pancreatic tumors via CD4+ T cells and CXCR3-dependent mechanisms.
bioRxiv · Feb 7, 2020 · PreprintCancer Biology